US 11584733
Selective histone deacetylase inhibitors for the treatment of human disease
granted A61KA61K31/45A61K31/454
Quick answer
US patent 11584733 (Selective histone deacetylase inhibitors for the treatment of human disease) held by Shuttle Pharmaceuticals, Inc. expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Shuttle Pharmaceuticals, Inc.
- Grant date
- Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/45, A61K31/454, A61K45/06, A61P